| Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease L Chouchana, C Narjoz, P Beaune, MA Loriot, X Roblin Alimentary pharmacology & therapeutics 35 (1), 15-36, 2012 | 176 | 2012 |
| “Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French Network of … A Gérard, S Romani, A Fresse, D Viard, N Parassol, A Granvuillemin, ... Therapies 75 (4), 371-379, 2020 | 147 | 2020 |
| Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns A Touafchia, H Bagheri, D Carrié, G Durrieu, A Sommet, L Chouchana, ... Clinical Microbiology and Infection 27 (5), 791. e5-791. e8, 2021 | 111 | 2021 |
| Chronic voluntary ethanol intake hypersensitizes 5‐HT1A autoreceptors in C57BL/6J mice S Kelaï, T Renoir, L Chouchana, F Saurini, N Hanoun, M Hamon, ... Journal of neurochemistry 107 (6), 1660-1670, 2008 | 67 | 2008 |
| Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring L Chouchana, C Narjoz, D Roche, JL Golmard, B Pineau, G Chatellier, ... Pharmacogenomics 15 (6), 745-757, 2014 | 63 | 2014 |
| Phenome-Wide Association Studies on a Quantitative Trait: Application to TPMT Enzyme Activity and Thiopurine Therapy in Pharmacogenomics A Neuraz, L Chouchana, G Malamut, C Le Beller, D Roche, P Beaune, ... PLoS computational biology 9 (12), e1003405, 2013 | 56 | 2013 |
| Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study C Mettler, AP Jonville-Bera, A Grandvuillemin, JM Treluyer, B Terrier, ... Rheumatology 61 (2), 865-867, 2022 | 45 | 2022 |
| Risk of scleroderma according to the type of immune checkpoint inhibitors B Terrier, S Humbert, LH Preta, L Delage, J Razanamahery, ... Autoimmunity Reviews 19 (8), 102596, 2020 | 45 | 2020 |
| Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach C Rasmussen, M Tisseyre, J Garon-Czmil, M Atzenhoffer, L Guillevin, ... Autoimmunity Reviews 20 (1), 102707, 2021 | 40 | 2021 |
| Rituximab or azathioprine maintenance in ANCA-associated vasculitis. L Chouchana, MA Beaune, Philippe, Loriot The New England journal of medicine 372 (4), 386, 2015 | 33* | 2015 |
| Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study L Chouchana, LH Preta, M Tisseyre, B Terrier, JM Treluyer, F Montastruc Kidney International 99 (5), 1235-1236, 2021 | 27 | 2021 |
| Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines L Chouchana, AA Fernández-Ramos, F Dumont, C Marchetti, ... Genome Medicine 7 (1), 37, 2015 | 27 | 2015 |
| Pharmacogenetics of immunosuppressants: state of the art and clinical implementation–recommendations from the French National Network of Pharmacogenetics (RNPGx) JB Woillard, L Chouchana, N Picard, MA Loriot, FN of Pharmacogenetics Therapies 72 (2), 285-299, 2017 | 26 | 2017 |
| Association of antihypertensive agents with the risk of in-hospital death in patients with Covid-19 L Chouchana, N Beeker, N Garcelon, B Rance, N Paris, E Salamanca, ... Cardiovascular Drugs and Therapy, 1-6, 2022 | 23 | 2022 |
| Dolutegravir and neural tube defects: a new insight L Chouchana, A Pariente, E Pannier, V Tsatsaris, JM Treluyer The Lancet Infectious Diseases 20 (4), 405-406, 2020 | 20 | 2020 |
| Is there a safety signal for dolutegravir and integrase inhibitors during pregnancy? L Chouchana, N Beeker, JM Treluyer JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (4), 481-486, 2019 | 20 | 2019 |
| Somatic augmentation strategies in clozapine resistance-what facts? C Tranulis, F Mouaffak, L Chouchana, E Stip, R Gourevitch, MF Poirier, ... Clinical neuropharmacology 29 (1), 34-44, 2006 | 20 | 2006 |
| Ocular safety profile of BRAF and MEK inhibitors: data from the World Health Organization pharmacovigilance database C Mettler, D Monnet, N Kramkimel, JM Tréluyer, L Mouthon, A Brézin, ... Ophthalmology 128 (12), 1748-1755, 2021 | 19 | 2021 |
| Beta‐lactam‐induced severe neutropaenia: a descriptive study T Vial, H Bailly, MC Perault‐Pochat, A Default, C Boulay, L Chouchana, ... Fundamental & Clinical Pharmacology 33 (2), 225-231, 2019 | 18 | 2019 |
| French Network of Pharmacogenetics (RNPGX). Pharmacogenetics of immunosuppressants: State of the art and clinical implementation—Recommendations from the French National … JB Woillard, L Chouchana, N Picard, MA Loriot Therapie 72 (2), 285-299, 2017 | 17 | 2017 |
